TQA, or Tomo Quality Assurance, is reportedly the first integrated, machine-specific quality assurance (QA) solution to be offered by a radiation therapy vendor. The TQA application streamlines the collection and simplifies the review of data used to monitor radiation therapy equipment and procedures. All TQA data can be exported for third-party validation.

TQA has been developed by TomoTherapy in partnership with medical physicists experienced in the clinical use of the Hi-Art treatment system.

The TQA application leverages the Hi-Art treatment system's platform integration. It works by gathering data from the on-board detector and other sub-systems that monitor the device continuously during delivery. The data is then presented in a customizable, calendar-based interface that is accessible from the Hi-Art system's operator station. With this comprehensive data dashboard, any parameter's status can be identified at a glance and comparatively assessed via automated reporting and trending features, said the company.


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | RSNA 2025

Nov. 25, 2025 — OmniZare will showcase its groundbreaking Dielectric Tomography Scanner platform at RSNA 2025 in Chicago ...

Time November 26, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
Subscribe Now